SOFIA-LTT Study: A Study of Intermittent Long Term Treatment With PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With HBeAg Negative Chronic Hepatitis B (CHB).

This study has been completed.

Study NCT00442572 Information provided by Hoffmann-La Roche

First Received on February 15, 2007. Last Updated on May 23, 2013 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Hepatitis B, Chronic

Additional conditions recognized in this trial

Hepatitis
Hepatitis A
Hepatitis B
Hepatitis, Chronic

More general conditions related to this trial

Interventions listed in this trial

Additional drug interventions recognized in this trial

More general drug interventions related to this trial

Sponsors listed in this trial

Hoffmann-La Roche